• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板活化因子增加肺微血管通透性并诱发肺水肿。初步报告。

Platelet-activating factor increases pulmonary microvascular permeability and induces pulmonary edema. A preliminary report.

作者信息

Mojarad M, Hamasaki Y, Said S I

出版信息

Bull Eur Physiopathol Respir. 1983 May-Jun;19(3):253-6.

PMID:6882949
Abstract

Platelet-activating factor, a naturally occurring lipid that is released from leukocytes and alveolar macrophages, increased the flow of protein-rich lymph from the lungs and induced pulmonary edema in dogs when given in picomolar doses. The pulmonary edema was due to increased microvascular permeability, probably secondary to endothelial cell injury. These observations suggest that platelet-activating factor may be a mediator of high-permeability pulmonary edema in the "respiratory distress syndrome" complicating acute lung injury.

摘要

血小板活化因子是一种天然存在的脂质,可从白细胞和肺泡巨噬细胞中释放出来,当以皮摩尔剂量给予时,会增加狗肺部富含蛋白质的淋巴液流动并诱发肺水肿。肺水肿是由于微血管通透性增加,可能继发于内皮细胞损伤。这些观察结果表明,血小板活化因子可能是急性肺损伤并发的“呼吸窘迫综合征”中高通透性肺水肿的介质。

相似文献

1
Platelet-activating factor increases pulmonary microvascular permeability and induces pulmonary edema. A preliminary report.血小板活化因子增加肺微血管通透性并诱发肺水肿。初步报告。
Bull Eur Physiopathol Respir. 1983 May-Jun;19(3):253-6.
2
Pentoxifylline attenuates platelet activating factor-induced permeable edema in isolated perfused guinea pig lungs.己酮可可碱减轻血小板活化因子诱导的离体灌注豚鼠肺通透性水肿。
Zhongguo Yao Li Xue Bao. 1994 May;15(3):219-22.
3
Platelet-activating factor and bacteremia-induced pulmonary hypertension.血小板活化因子与菌血症诱导的肺动脉高压
J Surg Res. 2000 Feb;88(2):173-80. doi: 10.1006/jsre.1999.5748.
4
Ultrastructural abnormalities in increased-permeability pulmonary edema.
Clin Chest Med. 1985 Sep;6(3):345-69.
5
Endothelial cell changes are associated with pulmonary edema and respiratory distress in mice infected with the WA1 human Babesia parasite.
J Parasitol. 1999 Jun;85(3):479-89.
6
Pulmonary permeability edema in a large animal model of nonpulmonary sepsis. A morphologic study.非肺部脓毒症大型动物模型中的肺通透性水肿。一项形态学研究。
Am J Pathol. 1987 Aug;128(2):241-51.
7
Nitric oxide opposes phorbol ester-induced increases in pulmonary microvascular permeability in dogs.一氧化氮可对抗佛波酯诱导的犬肺微血管通透性增加。
J Pharmacol Exp Ther. 1998 Feb;284(2):443-8.
8
Intravenous platelet activating factor does not affect lung epithelial permeability.静脉注射血小板活化因子不影响肺上皮通透性。
Res Commun Chem Pathol Pharmacol. 1987 Dec;58(3):405-8.
9
Rolipram and isoproterenol reverse platelet activating factor-induced increases in pulmonary microvascular permeability and vascular resistance.咯利普兰和异丙肾上腺素可逆转血小板活化因子引起的肺微血管通透性增加和血管阻力增加。
J Surg Res. 1995 Jul;59(1):159-64. doi: 10.1006/jsre.1995.1148.
10
The role of platelet-activating factor in the pulmonary response to inhaled bacterial endotoxin.
Am Rev Respir Dis. 1991 Jul;144(1):167-72. doi: 10.1164/ajrccm/144.1.167.

引用本文的文献

1
Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients.院前阿司匹林治疗与急性肺损伤的关联:一项对高危患者进行的多中心国际观察性研究的结果。
Crit Care Med. 2011 Nov;39(11):2393-400. doi: 10.1097/CCM.0b013e318225757f.
2
Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study.院前抗血小板治疗与急性肺损伤发生率降低相关:一项基于人群的队列研究。
Chest. 2011 Feb;139(2):289-295. doi: 10.1378/chest.10-0891. Epub 2010 Aug 5.
3
Platelet-activating factor causes ventilation-perfusion mismatch in humans.
血小板活化因子可导致人体通气-灌注不匹配。
J Clin Invest. 1994 Jan;93(1):188-94. doi: 10.1172/JCI116944.
4
Bronchial and vascular effects of Paf in the rat isolated lung are completely blocked by WEB 2086, a novel specific Paf antagonist.新型特异性血小板活化因子(PAF)拮抗剂WEB 2086可完全阻断PAF对大鼠离体肺支气管和血管的作用。
Br J Pharmacol. 1987 Aug;91(4):799-802. doi: 10.1111/j.1476-5381.1987.tb11278.x.
5
Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.血小板活化因子介导内毒素处理大鼠的血流动力学变化和肺损伤。
J Clin Invest. 1987 May;79(5):1498-509. doi: 10.1172/JCI112980.
6
PAF-acether induced cardiac dysfunction in the isolated perfused guinea pig heart.血小板活化因子(PAF-乙酰醚)在离体灌注豚鼠心脏中诱发心脏功能障碍。
Naunyn Schmiedebergs Arch Pharmacol. 1987 Oct;336(4):459-63. doi: 10.1007/BF00164883.
7
Body temperature modulates the effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit.体温可调节血小板活化因子(PAF)对兔气道反应性的影响。
Agents Actions. 1991 Mar;32(3-4):173-81. doi: 10.1007/BF01980870.
8
Bleomycin-induced lung injury in the rat: effects of the platelet-activating factor (PAF) receptor antagonist BN 52021 and platelet depletion.博来霉素诱导的大鼠肺损伤:血小板活化因子(PAF)受体拮抗剂BN 52021及血小板耗竭的影响
Environ Health Perspect. 1990 Apr;85:65-9. doi: 10.1289/ehp.85-1568314.
9
Platelet activating factor mediates interleukin-2-induced lung injury in the rat.血小板活化因子介导大鼠白细胞介素-2诱导的肺损伤。
J Clin Invest. 1992 May;89(5):1669-73. doi: 10.1172/JCI115765.